Breakthrough study finds single dose of psychedelics significantly reduced depression symptoms in clinical trial, with ...

"A single dose of DMT with psychotherapeutic support produced a rapid, significant reduction in depressive symptoms, ...

A study comparing individuals with persistent depressive disorder to those with episodic major depressive disorder found that those with persistent depression had lower treatment expectations. These ...

Dimethyltryptamine’s short duration of psychedelic effects makes it a potentially practical alternative to other ...

People taking DMT tended to experience significant relief from their depression for up to three months, the researchers found ...

In two large-scale trials, Compass Pathways' proprietary form of psilocybin improved people's depression symptoms better than controls.

Discover how TMS therapy targets depression at the source. A deep dive into the physics, safety protocols, and FDA-cleared ...

—Researchers recently examined the impact of depressive symptoms, as measured by the 21-item Beck Depression Inventory, on adherence to therapy using correlation, network analysis, and linear ...

Actigraphy data show irregular sleep-wake rhythms nearly double the risk for relapse in individuals with remitted major depressive disorder.

Spravato (esketamine) is a nasal spray used for depression and was approved by the FDA in 2019. It is specifically for treatment-resistant depression, meaning depression symptoms that have not gotten ...

The approval of medicines called second-generation antipsychotics has allowed major depressive disorder (MDD) and other conditions linked to it to be treated. A person with MDD is usually prescribed ...